No Data
Here Are the Major Earnings After the Close Today
What Makes Ultragenyx Pharmaceutical (RARE) an Exciting Investment Opportunity?
Earnings Preview: RARE to Report Financial Results Post-market on November 05
$Ultragenyx Pharmaceutical(RARE.US)$ is scheduled to release its financial results post-market on November 05 ET. Earnings PreviewAnalysts estimate $Ultragenyx Pharmaceutical(RARE.US)$ to post
Ultragenyx to Host Conference Call for Third Quarter 2024 Financial Results and Corporate Update
Recent 4.1% Pullback Isn't Enough to Hurt Long-term Ultragenyx Pharmaceutical (NASDAQ:RARE) Shareholders, They're Still up 70% Over 1 Year
Piper Sandler Maintains Ultragenyx Pharmaceutical(RARE.US) With Buy Rating, Maintains Target Price $135